VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Combination Simvastatin plus Ezetimibe
Preclinical
Small molecule
F
Federal University of São Paulo
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Inflammation
1 trial
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
Completed
·
F
Federal University of São Paulo
·
N/A
·
NCT01103648
·
50 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Combination Simvastatin plus Ezetimibe. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Combination Simvastatin plus Ezetimibe compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Combination Simvastatin plus Ezetimibe. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Federal University of São Paulo company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
F
Federal University of São Paulo
Related News